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Mechanistic studies on the effect of membrane lipid acyl chain
composition on daptomycin pore formation
David Beriashvili1, Robert Taylor1, Braden Kralt, Nooran Abu Mazen, Scott D. Taylor,
Michael Palmer∗
Department of Chemistry, University of Waterloo, Waterloo, ON N2L 3G1, Canada
Abstract
Daptomycin is a lipopeptide antibiotic that binds and permeabilizes the cell mem-
branes of Gram-positive bacteria. Membrane permeabilization requires both cal-
cium and phosphatidylglycerol (PG) in the target membrane, and it correlates with
the formation of an oligomer that likely comprises eight subunits, which are evenly
distributed between the two membrane leaflets. In both bacterial cells and model
membranes, changes in the fatty acyl composition of the membrane phospholipids
can prevent permeabilization. We here used liposomes to study the effect of phos-
pholipids containing oleoyl and other fatty acyl residues on daptomycin activity, and
made the following observations: 1) Oleic acid residues inhibited permeabilization
when part not only of PG, but also of other phospholipids (PC or cardiolipin). 2) When
included in an otherwise daptomycin-susceptible lipid mixture, even 10% of dioleoyl
lipid (DOPC) can strongly inhibit permeabilization. 3) The inhibitory effect of fatty
acyl residues appears to correlate more with their chain length than with unsaturation.
4) Under all conditions tested, permeabilization coincided with octamer formation,
whereas tetramers were observed on membranes that were not permeabilized. Overall,
our findings further support the notion that the octamer is indeed the functional trans-
membrane pore, and that fatty acyl residues may prevent pore formation by preventing
the alignment of tetramers across the two membrane leaflets.
Keywords: calcium-dependent lipopeptide antibiotics, phosphatidylglycerol,
cardiolipin, membrane fluidity, membrane permeabilization
1. Introduction
The lipopeptide antibiotic daptomycin is used clinically to treat infections with
Gram-positive bacteria such as Staphylococcus aureus and Enterococcus faecium. It
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binds to calcium and to phosphatidylglycerol in the cytoplasmic membrane [1]. It
then oligomerizes [2, 3] and permeabilizes the membrane. In certain model lipo-
somes, oligomerization is accompanied by the formation of cation-selective pores [4].
Our current working model postulates that the oligomeric pore comprises eight dap-
tomycin molecules overall and consists of two tetramers, which reside in the inner and
the outer membrane leaflet, respectively [5].
The existence of such pores may also account for various experimental observa-
tions on Gram-positive bacteria, namely, the depolarization of the cell membrane [6–8]
with concomitant disruption of amino acid uptake [6, 9] and the release of K+ from the
cells [8, 9]; in contrast, the membrane remains impervious to the negatively charged
permeability probe calcein [10]. A recent study [11], however, did not detect direct per-
meabilization of Bacillus subtilis cells for K+, whereas delayed, partial membrane de-
polarization was still observed. This study also documented the dissociation of biosyn-
thetic enzymes from the cell membrane, as well as changes in membrane lipid dynam-
ics, to which the authors ascribed the observed membrane depolarization.
While oligomerization of daptomycin has been implicated in its bactericidal activ-
ity on Bacillus subtilis [3], the observations reported in [11] suggest that the bacterici-
dal effect may not arise from direct pore formation. It has recently emerged that, both
in model membranes [12] and in bacterial cells [13, 14], the fatty acyl composition of
the membrane phospholipids can affect daptomycin activity. Model liposomes com-
posed of dimyristoyl-phosphatidylcholine (DMPC) and -phosphatidylglycerol (DMPG)
are readily permeabilized by daptomycin [4]; in these lipids, both fatty acyl chains are
14 carbon atoms long and contain no double bonds (14:0/14:0; for lipid structures, see
Figure S1). In contrast, liposomes that contain palmitoyl-oleoyl lipids (POPC/POPG;
16:0/18:1) or dioleoyl lipids (DOPC/DOPG; 18:1/18:1) are not permeabilized [12]. We
here examine in more detail the effect of fatty acyl composition of PC/PG model mem-
branes on daptomycin pore formation, as well as on other aspects of its activity.
2. Materials and Methods
For brevity, methods are described here only in outline, and the pertinent refer-
ences are cited. Where indicated, additional detail is given in the Supplementary Ma-
terials.
2.1. Antibacterial Activity Assay
Daptomycin and its semisynthetic derivatives were tested against Bacillus subtilis
ATCC 1046 by broth microdilution as described in [12]. Further detail is given in the
Supplementary Materials.
2.2. Liposome preparation
All the lipids used in this study were acquired from Avanti Polar Lipids (Al-
abaster, Alabama). Lipids include: 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC), 1,2-dimyristoyl-sn-glycero-3phospho-(1’-rac-glycerol) (sodium salt; DMPG),
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(1’-rac-glycerol) (sodium salt; DOPG), 1’,3’-bis[1,2dimyristoyl-sn-glycero-3-phospho]-
sn-glycerol (sodium salt; TMCL), 1’,3’-bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glyc-
erol (sodium salt; TOCL), 1,2-dipentadecanoyl-sn-glycero-3phosphocholine (DPDPC),
and 1,2-dimyristoleoyl-sn-glycero-3-phosphocholine (DMPC-∆9-Cis). The lipids were
dissolved into chloroform and methanol (3:1) and were used without further purifica-
tion. The structures of all lipids used in this study are shown in the Supplementary
Materials (Figure S1).
Large unilamellar vesicles (LUVs) were prepared using the polycarbonate mem-
brane extrusion method [15] as detailed before [2]. Further detail is given in the Sup-
plementary Materials.
2.3. Kynurenine fluorescence
The intrinsic fluorescence of daptomycin’s kynurenine residue, which increases
upon membrane binding [16], was measured using excitation and emission wave-
lengths of 365 and 445 nm, respectively. These measurements (as well as all other
fluorescence measurements) were carried out in a QuantaMaster 4 steady-state spec-
trofluorimeter (PTI, London, ON).
2.4. Membrane Permeabilization Assay
This assay was carried out as described before in [12]. The results shown are the
average of 6 independent experiments each. Assays were run at a temperature higher
than the phase transition (see Results for specific temperatures). Further detail is given
in the Supplementary Materials.
2.5. Daptomycin subunit stoichiometry
These experiments were carried out essentially as described in [17]. Further detail is
given in the Supplementary Materials. The results shown are the averages and standard
deviations of eight independent experiments.
2.6. Daptomycin bilayer translocation
The distribution of daptomycin between the outer and the inner membrane leaflets
of liposomes was measured using dithionite quenching [18]of NBD-daptomycin essen-
tially as described in [12]. The results shown are the averages and standard deviations
of three independent experiments. Further detail is given in the Supplementary Mate-
rials.
2.7. Fluorescence assay of membrane fluidity
The phase transition temperatures of liposomes containing tetra-myristoyl-cardiolipin
(TMCL) or di-pentadecanoyl-phosphatidylcholine (DPDPC) were determined using
the diphenylhexatriene polarization assay [19]. 1,6-Diphenyl-1,3,5-hexatriene (DPH;
Millipore-Sigma) dissolved in methanol was added to liposomes in a 1 mL cuvette to a
final concentration of 10 µM, followed by incubation for 10 minutes. For fluorescence
anisotropy measurements, DPH was excited at 350 nm and emission measured at 428
nm.
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2.8. Synthesis of NBD-daptomycin and of C14-daptomycin
These were synthesized essentially according to previously reported methods [2,
20]. Further detail is given in the Supplementary Materials.
3. Results
3.1. Inhibition of daptomycin by oleoyl residues is independent of the phospholipid head
group
Previous studies have shown that PG in the target membrane mediates high-affinity
binding, conformational change, and oligomerization of daptomycin [2, 21]. Moreover,
membrane levels of PG are strongly correlated with bacterial susceptibility to dapto-
mycin [1, 13, 22–25]. In contrast, PC alone permits low-affinity binding, but it fails to
induce the subsequent stages of activity [2, 21]. Since daptomycin activity thus depends
on PG, the question arises whether oleoyl residues inhibit permeabilization only if they
are part of this specifically required phospholipid, or also if they are part of an inert
“bulk” lipid such as PC.
In the experiments shown in Figure 1, the activity of daptomycin was measured
on membranes composed of DMPC and DMPG, as well as of various combinations of
these with dioleoyl lipids as indicated. This assay measures the effect of daptomycin
indirectly: when daptomycin permits the influx of sodium into the liposomes, pro-
tons are released in exchange by the protonophore CCCP. The accompanying change of
pH is then detected by an increase in the fluorescence of the pH-sensitive fluorophore
pyranine entrapped inside the liposomes [4, 26].
Figure 1A shows that daptomycin readily permeabilizes DMPC/DMPG mem-
branes, which agrees with previous findings [4]. In contrast, membranes in which
either DMPC or DMPG is replaced with the corresponding dioleoyl lipid are not per-
meabilized (Figure 1B,C). Thus, oleoyl acyl chains inhibit daptomycin even if they
are not covalently associated with the PG head group. This indicates that, while the
PG head group is specifically required for daptomycin binding, other lipids (PC in
this case) are part of the microenvironment that controls the activity of membrane-
bound daptomycin. Furthermore, even at a molar fraction as low as 10%, DOPC still
suppresses permeabilization; the inhibition only wanes once DOPC is reduced to 5%
(Figure 1D,E). Thus, the inhibitory action of DOPC is remarkably strong.
3.2. Mechanistic aspects of the inhibition of permeabilization by dioleoyl lipids
In our previous study [12], we showed that DOPC/DOPG membranes bind dap-
tomycin at lower calcium concentrations, and thus more avidly, than DMPC/DMPG
membranes; the greater bulk of the oleoyl chains may distend the head group layer,
which may help accommodate daptomycin in the membrane (cf. [5]). Therefore, a
conceivable explanation for the high inhibitory potency of dioleoyl lipids in mixed
membranes with dimyristoyl lipids would be that they create high-affinity binding
sites which sequester daptomycin and prevent it from interacting with DMPC/DMPG.
However, as Figure 2 shows, neither DOPC/DMPG nor DMPC/DOPG membranes ex-
ceed the daptomycin affinity of DMPC/DMPG membranes. Therefore, daptomycin
does not bind preferentially to dioleoyl lipids in mixtures with dimyristoyl lipids.
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Figure 1: Permeabilization of LUVs composed of DOPC or DMPC and DOPG or DMPG in various pro-
portions, as indicated. LUVs were loaded with the pH-sensitive fluorescent dye pyranine at pH 6, diluted
into a buffer with pH 8, and exposed to the proton ionophore CCCP (5 nM) and to daptomycin (2 µM). An
increase in fluorescence indicates membrane permeabilization for both protons and sodium ions. Solu-
bilization with Triton-X100 abolishes the pH gradient and provides a reference value for 100% permeabi-
lization [4, 12, 26].
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Figure 2: Calcium-dependent binding of daptomycin to liposomes composed of equimolar mixtures of
DMPC or DOPC with DMPG or DOPG as indicated. Membrane binding is detected by the concomitant
increase in the intrinsic fluorescence of daptomycin’s kynurenine residue [16]. Error bars represent stan-
dard deviations from four independent experiments.
With pure DOPC/DOPG membranes, we had previously found that daptomycin
formed tetramers rather than octamers, and moreover that these tetramers were un-
evenly distributed between the two membrane leaflets, such that approximately two
thirds remain in the outer leaflet [12]. Since our working model assumes that the pore
is octameric, the observed inhibition of octamer formation by dioleoyl lipids accounts
for the lack of pore formation. On the other hand, it seemed possible that at a mere
10% of dioleoyl lipids, octamers might still form, which would however fail to perme-
abilize the membrane; such non-functional oligomers have been described with some
pore-forming protein toxins on non-susc ptible cell types [27, 28].
The subunit stoichiometry of dap omycin oligomers was determined by a pre-
viously reported FRET method [17], whereas the distribution of daptomycin across
leaflets was measured using dithionite quenching of NBD-labeled daptomycin [4, 12].
Somewhat to our surprise, we found that indeed both the subunit stoichiometry and
the distribution across leaflets was closely similar between pure DOPC/DOPG mem-
branes and those that contained a mere 10% DOPC combined with 40% DMPC and
50% DMPG (Figure 3). In contrast, on pure DMPC/DMPG membranes, the oligomer
subunit stoichiometry was close to eight—slightly lower, in fact, as it usually is; pos-
sible reasons have been discussed before [5, 17]—and the distribution of daptomycin
across leaflets was close to even.
As reported previously [12], the uneven distribution of daptomycin between leaflets
of membranes containing dioleoyl lipids did not change after prolonged incubation
and thus likely reflects the equilibrium. The asymmetry might be explained by the
lack of calcium inside these liposomes, which would destabilize oligomers bound to
the inner leaflet. In contrast, the pores on DMPC/DMPG liposomes would most likely
admit calcium to the interior, which would stabilize oligomers bound to the inner
leaflet. (This has not been directly demonstrated, since at the concentration required
for the permeant ion in our permeability assay [100 mM], Ca++ causes the liposomes
to aggregate; but two other divalent cations have been shown to cross the membrane
6





































































Figure 3: Oligomer subunit stoichiometry and translocation to the inner membrane leaflet of daptomycin
on PC/PG liposomes differing in acyl chain composition. Liposomes labeled with “10% DOPC” consisted
of DMPC (40%) and DMPG (50%) otherwise. Data for pure DMPC/DMPG membranes were adapted from
[5]. Error bars indicate standard deviations of 3 or more experiments.
[4]). However, adding the calcium ionophore ionomycin to DOPC/DOPG liposomes—
either alone, or together with CCCP to render the influx of calcium electroneutral by
permitting an efflux of protons—did not increase the extent of daptomycin transloca-
tion (Figure S6). We conclude that the asymmetric distribution of daptomycin across
membranes that contain dioleoyl lipids is not caused by a lack of calcium on the inside.
This question will be revisited in the discussion.
3.3. Revisiting the effect of cardiolipin on daptomycin activity
We previously reported that addition of cardiolipin to DMPC/DMPG membranes
at a molar fraction of 10 or 20% inhibits daptomycin pore formation, as well as its
translocation to the inner membrane leaflet; and we ascribed this inhibitory effect to
cardiolipin’s head group [5]. However, the particular species of cardiolipin used in our
earlier study was TOCL, which means that the membranes contained an amount of
oleoyl groups that has now turned out to be inhibitory apparently regardless of the lipid
head group. This raises the possibility that the fatty acyl chains of TOCL, rather than its
head group, were really causing the inhibition observed earlier. To decide this question,
we prepared liposomes that contained TMCL (10 or 20%) in combination with DMPG
(50%) and DMPC (to 100%); that is, the membranes contained some cardiolipin head
groups but only myristoyl residues.
In preliminary experiments, we observed that TMCL dose-dependently increased
the gel-to-liquid transition temperature of the membranes (Figure 4A), and further-
more that 20% TMCL prevented the stable encapsulation of pyranine, our fluorescence
probe for membrane permeabilization. All further experiments were therefore con-
ducted with 10% TMCL and at 30°C, at which temperature the membranes are in the
fluid state and do not leak pyranine.
Unlike membranes consisting of DMPC and DMPG only (cf. Figure 1A), mem-
branes containing TMCL are only weakly permeabilized by 2 µM daptomycin (Figure
4C). However, when these liposomes were treated with 10 µM daptomycin, they were
permeabilized to a greater degree than another sample that contained an equal amount
7
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Figure 4: Characterization of daptomycin activity on liposomes containing TMCL (A, C, D) or TOCL (B)
together with DMPG (50%) and DMPC (to 100%). A: Fluorescence polarization of diphenylhexatriene
(DPH). The polarization drops as the membrane transitions from the gel to the fluid state [29]. B: Pyranine
permeabilization assay on liposomes containing 10% TOCL by 2 and 10µM daptomycin. C: Pyranine per-
meabilization assay on liposomes containing 10% TMCL by 2 and 10 µM daptomycin. Traces are colored
and patterned as in A. D: Oligomer subunit stoichiometry and translocation to inner membrane leaflet of
daptomycin on membranes containing 10% TMCL. ‘Low’ daptomycin concentrations were 2 and 3 µM
daptomycin for stoichiometry and translocation, while ‘high’ one were 10 µM and 8 µM, respectively.
of TOCL instead of TMCL (Figure 4B). Therefore, in keeping with our previous report
[5], the cardiolipin head group on its own indeed has an inhibitory effect, yet the oleoyl
residues of TOCL endow it with greater inhibitory potency than TMCL.
As an aside, with both TMCL and TOCL, daptomycin at 10 µM caused a significant
rise in pyranine fluorescence intensity even without the protonophore CCCP. As dis-
cussed earlier [4, 26], an efflux of protons is required to maintain electroneutrality as
sodium enters the liposomes. It thus appears that, at sufficiently high concentrations,
daptomycin can cause a significant efflux of protons by itself; we have previously ob-
served a similar effect with a dimeric derivative of daptomycin even at lower concen-
trations [20].
Finally, we also measured daptomycin oligomer subunit stoichiometry as well as
translocation to the inner membrane leaflet on TMCL-containing liposomes, at differ-
ent daptomycin concentrations. We observed that both the number of subunits and
the extent of translocation to the inner leaflet increased as the daptomycin concen-
tration was raised from non-permeabilizing to permeabilizing levels (Figure 4D). This
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appears consistent with the earlier conclusion that permeabilization correlates with
the formation of the membrane-spanning octamer.
3.4. Is inhibition caused by acyl chain length or unsaturation?
The acyl chains in DOPC/DOPG and POPC/POPG, which form membranes that are
impervious to daptomycin permeabilization, differ from those in susceptible model
membranes (DMPC/DMPG) with respect to both chain length and degree of unsatu-
ration. This raises the question if either or both of these traits are responsible for the
inhibition. To answer it, we prepared liposomes that contained 10% of a PC species
that differed from DMPC (di-C14:0-PC) either in length only (DPDPC; di-C15:0-PC) or
in saturation only (DMPC-∆9-Cis; di-C14:1-PC). Figure 5 shows the permeabilization
of these two liposome species. Both showed some leakage even when either or both of
daptomycin and CCCP were absent, yet it is apparent that di-C14:1-PC is more permis-
sive toward daptomycin-mediated permeabilization than is di-C15:0-PC. This suggests
that acyl chain length has a greater effect on permeabilization than unsaturation.
The reader may note that most of the unbranched fatty acyl residues found in bac-
terial membranes have even numbers of carbons. We nevertheless chose DPDPC (di-
C15:0-PC) for this experiment rather than dipalmitoyl-PC (di-C16:0-PC) or distearoyl-
PC (di-C18:0-PC) in order to minimize effects such as decreased membrane fluidity
and lateral phase segregation, which become more likely with increasing difference in
acyl chain length. Figure S8 shows that mixed membranes with up to 20% of di-C15:0-
PC indeed remain in the fluid phase at the temperature of the permeabilization assay
(30°C).
3.5. Does the length of the daptomycin acyl chain affect the lipid permeability threshold?
Previous experiments with a pyrene-acyl-labeled daptomycin analogue suggest
that daptomycin’s N-terminally attached fatty acyl chain participates in the trans-
membrane interaction that joins two tetramers in opposed membrane leaflets into
an octamer [30]. Considering that oleoyl residues disrupt the alignment of tetramers
between leaflets, and that this inhibition appears to correlate with fatty acyl chain
length, the question arises if inhibition can be countered by extending the length of
daptomycin’s fatty acyl residue. Thus, we semisynthetically prepared a daptomycin
derivative in which the N-terminal decanoyl residue was replaced by myristoyl residue
(C14-daptomcyin). The MIC of this derivative on B. subtilis closely resembled that of
native daptomycin (0.5µg/ml and 0.75µg/ml, respectively). It was tested on a series of
membranes containing dimyristoyl-, dioleoyl-, or palmitoyl-oleoyl lipids. In all cases,
the activity C14-daptomycin closely resembled that of native daptomycin (see Figure
S7). Therefore, at least with this derivative, we obtained no evidence that the length of
daptomycin’s fatty acyl residue controls its susceptibility to inhibition by membrane
lipids.
4. Discussion
In this study, we have shown that oleoyl and other fatty acyl residues in phospho-
lipids can potently inhibit the formation of daptomycin pores in otherwise susceptible
9































































Figure 5: Permeabilization of liposomes that contain 10% DPDPC (A) or DMPC-∆9-Cis (B), respectively,
in combination with 40% DMPC and 50% DMPG. Daptomycin (Dap), where present, was used at 2 µM.
Curves in B are colored as in A. Each curve represents the average of triplicate experiments.
membranes. This inhibitory effect appears to correlate with the chain length rather
than with degree of unsaturation of the fatty acyl residue in question, and furthermore
to not be restricted by the head group of the phospholipid. On the other hand, the re-
ported observations with TMCL show that the cardiolipin head group can also inhibit
permeabilization, which confirms our previous conclusion [5]. Furthermore, the in-
hibitory effects of both acyl chains and head groups are manifest at remarkably low
molar fractions of the lipids in question.
Bacterial membranes represent fairly complex mixtures of lipids, with respect to
both acyl chains and head groups, and lateral lipid segregation and domain formation
will further diversify the membrane composition. In light of this, one might expect bac-
terial species to differ in their susceptibility to cation-selective membrane permeabi-
lization by daptomycin [8, 9, 11], and furthermore that even minor shifts in membrane
lipid composition may significantly alter daptomycin susceptibility [13, 14]. The latter
two studies found that an increase in the fraction of longer acyl chains in the mem-
brane lipids of Staphylococcus aureus correlates with daptomycin resistance, which
agrees with our observations in model membranes. It must be noted, however, that
membrane lipids of S. aureus and also other Gram-positives contain a large fraction of
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branched fatty acyl chains, whose effect on daptomycin activity remains to be eluci-
dated.
One further comment is in order regarding the relevance of this study to bacte-
rial cells. Firstly, the neutral component of our model membranes was phosphatidyl-
choline; while this lipid is not a major component of bacterial cell membranes, we
made this choice in order to keep the experiments consistent and comparable with
previous studies by others [21, 31–33] and ourselves [4, 5, 12].
Our study further corroborates the hypothesis that cation-selective permeabiliza-
tion, which is observed on DMPC/DMPG model membranes [4] and at least some bac-
teria [8, 9], is caused by a daptomycin octamer that spans both membrane leaflets [5].
Complete conversion of membrane-bound daptomycin to this octameric form implies
an even distribution between both leaflets, which is indeed observed on the suscepti-
ble (DMPC/DMPG) model membranes. On the other hand, if they do not connect,
then the tetramers should remain free to partition independently between leaflets; and
whenever tetramers predominate, they exhibit a preference for the outer leaflet. This
preference is not driven by calcium; it may be due to the difference in curvature strain
between the two leaflets. We note that the (considerably larger) curvature strain in the
division septum of Bacillus subtilis cells has previously been implicated in the prefer-
ential binding of daptomycin to this structure [34]. In any case, our findings do confirm
that daptomycin can translocate to the inner leaflet of lipid membranes even if it fails to
then permeabilize them, which suggests that bactericidal mechanisms which involve
the interaction of daptomycin with proteins at the inner surface of such membranes
[11] are feasible in principle.
While the interpretation given above is based on the assumption that the dapto-
mycin oligomer itself is the functional transmembrane pore [5, 8], we cannot rule out
that the observed inhibitory effects of oleoyl and other fatty acyl residues might be
accounted for by the lipid phase segregation model of membrane permeabilization
[11, 35]. This possibility will be addressed in a future experimental study.
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• Daptomycin forms cation-selective, octameric pores in membranes containing PG 
• Pore formation is inhibited by phospholipids with acyl chains longer than 14 carbons 
• Inhibition occurs even if the acyl chains are part of the “bulk” lipid, not of PG  
• Inhibition is observed with low percentages (10%) of inhibitory phospholipid 
• When inhibitory lipids are present, daptomycin forms tetramers rather than octamers 
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